Cargando…
Cell-free circulating tumor DNA in cancer
Cancer is a common cause of death worldwide. Despite significant advances in cancer treatments, the morbidity and mortality are still enormous. Tumor heterogeneity, especially intratumoral heterogeneity, is a significant reason underlying difficulties in tumor treatment and failure of a number of cu...
Autores principales: | Qin, Zhen, Ljubimov, Vladimir A., Zhou, Cuiqi, Tong, Yunguang, Liang, Jimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823888/ https://www.ncbi.nlm.nih.gov/pubmed/27056366 http://dx.doi.org/10.1186/s40880-016-0092-4 |
Ejemplares similares
-
PTTG Acts As a STAT3 Target Gene for Colorectal Cancer Cell Growth and Motility
por: Zhou, Cuiqi, et al.
Publicado: (2013) -
Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2016) -
Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019) -
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
por: Cheng, Xianliang, et al.
Publicado: (2017) -
PTTG1 Attenuates Drug-Induced Cellular Senescence
por: Tong, Yunguang, et al.
Publicado: (2011)